In LAD-1 patients, a mutation in the CD18 gene leads to the attenuated expression of functional heterodimeric β2 integrins, resulting in impaired leukocyte adhesion and migration into the tissue [237] and attenuated pathogen-killing functions, e.g., of PMN [238]. The gene discussed is ITGB2; the disease is leukocyte adhesion deficiency 1.